Patents by Inventor James Brian JAQUITH

James Brian JAQUITH has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220112242
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I: compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Application
    Filed: December 29, 2021
    Publication date: April 14, 2022
    Inventors: STEPHEN PAUL ARNS, JAMES BRIAN JAQUITH, DAVY JEREMY BAUDELET, ERIC ROY SIMONSON, RICHARD TOM LIGGINS, NAG SHARWAN KUMAR, TOM HAN HSIAO HSIEH
  • Patent number: 11279732
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: March 22, 2022
    Assignee: CDRD VENTURES INC.
    Inventors: Stephen Paul Arns, James Brian Jaquith, Davy Jérémy Baudelet, Eric Roy Simonson, Richard Tom Liggins, Nag Sharwan Kumar, Tom Han Hsiao Hsieh
  • Publication number: 20190040102
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Application
    Filed: February 9, 2017
    Publication date: February 7, 2019
    Inventors: Stephen Paul ARNS, James Brian JAQUITH, Davy Jérémy BAUDELET, Eric Roy SIMONSON, Richard Tom LIGGINS, Nag Sharwan KUMAR, Tom Han Hsiao HSIEH
  • Publication number: 20180312493
    Abstract: The present invention relates to compounds of formula (I) wherein G1 to G8 are as defined herein. The compounds are PK inhibitors and as such represent a new approach to treating pathogenic infections, including multidrug resistant pathogens. Disclosed herein are the compounds of formula (I), pharmaceutical compositions comprising the compounds of formula (I) and their use in the treatment of antimicrobial infection.
    Type: Application
    Filed: November 4, 2016
    Publication date: November 1, 2018
    Inventors: Robert Norman Young, Nag Sharwan Kumar, Alexander Laurence Mandel, Tom Han Hsiao Hsieh, Jason Samuel Tan, Fahimeh S. Shidmoossavee, James Brian Jaquith, Edith Mary Dullaghan
  • Publication number: 20170216252
    Abstract: Compounds of general formula I that are capable of inhibiting bacterial pyruvate kinase and/or bacterial growth. The compounds may find use as antibacterial agents in therapeutic and/or non-therapeutic contexts.
    Type: Application
    Filed: July 10, 2015
    Publication date: August 3, 2017
    Inventors: Robert N. YOUNG, Nag Sharwan KUMAR, Christophe LABRIERE, Jon Paul SELVAN, James Brian JAQUITH, Edith Mary DULLAGHAN